ECTRIMS 2018: Berlin im Zeichen der Multiplen Sklerose

Von 10. bis 12. Oktober 2018 findet zum 34. Mal der jährliche Kongress des European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) statt, zu dem rund 8.500 Teilnehmerinnen und Teilnehmer erwartet werden.


Beim 34. Jahreskongress des europäischen Komitees zur Behandlung und Erforschung der Multiplen Sklerose (ECTRIMS) treffen sich im City Cube Berlin Forschende, Neurologinnen und Neurologen sowie an Multipler Sklerose interessierte Medizinerinnen und Mediziner sämtlicher Fachrichtungen. Insgesamt werden 1.975 Studien und die neuesten Entwicklungen aus den Bereichen Epidemiologie, Pathologie, Bildgebung, Therapie, Immunologie, Genetik, Therapie und Biotechnologie vorgestellt.

Aus Österreich reisen Univ.-Prof. Dr. Thomas Berger, MSc,  Univ.-Prof. Dr. Hans Lassmann, Univ.-Prof. Dr. Franz Fazekas, Univ.-Prof. Dr. Karin Zebenholzer, Univ.-Prof. PD Dr. Michael Khalil, PhD, Univ.-Prof. Dr. Christian Enzinger, Assoc. Prof. Priv.-Doz. Dr. Romana Höftberger, Assoc. Prof. Univ.-Doz. Dipl.-Biol. Dr. Monika Bradl, Univ.-Prof. Dr. Markus Reindl, Margarete Voortman, MSc., OA Dr.Michael Guger, Livia Hofer, MSc, Dr. Alexander Pichler, Dr. Julia Feige, Dr. Christian Bsteh, Dipl.-Ing. Lukas Pirpamer und viele andere Forscherinnen und Forscher an.


Mittwoch, 10. Oktober 2018

Hot Topic 1: Hot topics in MS neuropathology 08:00-08:45
Educational Session 1: Pregnancy management in MS 08:00-09:30
Educational Session 2: Practical treatment recommendations based on new guidelines in MS 08:00-09:30
Educational Session 3: Neurofilament light chains in MS: where do we stand, the long road to clinical application 08:00-09:30
Educational Session 5: Impact and management of comorbidities in MS 08:00-09:30
Educational Session 4: Immunology of MS 08:00-09:30
Hot Topic 2: Digital MS: improving data acquisition and analysis 08:55-09:40
Young Scientific Investigators‘ Session 1: Imaging 09:00-10:15
Hot Topic 3: Biosimilars and follow-ups 09:45-10:30
Hot Topic 4: New approaches for microscopic and macroscopic imaging 09:45-10:30
Hot Topic 5: Mechanisms of CNS autoimmunity 09:45-10:30
Case-based Educational Session 6: How to manage non-response to highly active (second line) drugs? 09:45-10:30
Case-based Educational Session 7: Progressive MS: who should be treated and how to monitor treatment response? 09:45-10:30
Case-based Educational Session 8: Should all MS patients be treated? 09:45-10:30
Plenary Session 1: Welcome and ECTRIMS Lecture 11:00-12:15
Satellite Symposium 1: Data • Analysis • Technology • Application developments on the frontiers of MS 12:30-13:30
Satellite Symposium 2: THC: CBD in multiple sclerosis spasticity symptoms: newest evidence confirming efficacy and safety 12:30-13:30
Scientific Session 1: How real world data can inform treatment decisions 13:30-15:00
Scientific Session 2: Paediatric MS 13:30-15:00
Educational Session 9: Clinical trials in MS: the need for novelty 13:30-15:00
Educational Session 10 (IMSCOGS): Innovation in MRI in relation to cognitive and neuropsychiatric phenomena in MS 13:30-15:00
Educational Session 11: Molecular mechanisms of tissue injury in cortical MS lesions 13:30-15:00
European Charcot Foundation Symposium: Towards imaging biomarkers for disease progression in MS 13:45-14:45
Young Scientific Investigators‘ Session 2: Immunology/Neurobiology 13:45-15:00
Nurses‘ Session 1: Digital solutions 13:45-15:00
Scientific Session 3: Risk management with MS therapies 15:30-17:00
Burning Debate: The new McDonald diagnostic criteria are controversial making them difficult to use in clinical practice 15:30-17:00
Scientific Session 4 (IMSCOGS): Cognition in MS 15:30-17:00
Young Scientific Investigators‘ Session 3: Clinical 15:30-16:45
Nurses‘ Session 2: MS Nursing around the world 15:30-16:45
Educational Session 12: MS mimicks: other neuro-inflammatory disorders 15:30-17:00
Educational Session 13: Genetics and biomarkers in MS 15:30-17:00
Educational Session 14: Myelin repair in MS 15:30-17:00
Poster Session 1 17:00-19:00
Satellite Symposium 3: Disease activity: can starting early with effective treatment offer better outcomes in MS? 18:15-19:15
Satellite Symposium 4: Committing to generations, impacting patients: advancing disease management across the continuum of MS       18:15-19:15

Donnerstag, 11. Oktober 2018

Satellite Symposium 5: Disease progression: changing how we think about MS 07:30-08:30
Educational Session 15: Disease modifying treatments in MS 08:00-09:30
Educational Session 16 (RIMS): Symptomatic treatment of MS: how to manage pain/bladder/bowel/sexual dysfunction?                      08:00-09:30
Free Communications 1: New diagnostic criteria 08:30-09:30
Free Communications 2: Clinical 08:30-09:30
Free Communications 3: Neuroimmunology 08:30-09:30
Scientific Session 5: Predicting the course of newly diagnosed patients: insights from cohorts 10:00-11:30
Scientific Session 6: VISION research in MS: state of the art and future prospects 10:00-11:30
Scientific Session 7: Environmental risk factors of MS 10:00-11:30
Educational Session 17: MS pathology for clinical neurologists 10:00-11:30
Educational Session 18: Experimental neuroimmunology 10:00-11:30
Meet the Expert 1: Clinical treatment issues in NMO 10:00-11:00
Hot Topic 6: „Hitting hard and early“ or stepwise escalation: What is the best strategy? 11:45-12:30
Hot Topic 7: Imaging of neuronal structure and function to understand disease progression 11:45-12:30
Hot Topic 8: Emerging high throughput technologies: challenges and opportunities 11:45-12:30
Hot Topic 9: Science & art of symptomatic treatment 11:45-12:30
Case-based Educational Session 19: Paediatric MS 11:45-12:45
Meet the Expert 2: Differential diagnosis 12:00-13:00
Satellite Symposium 6: Evolving MS treatment with immune reconstitution therapy 13:00-14:00
Satellite Symposium 7: Committing to patients, impacting individuals: towards an individualised approach for patients with MS 13:00-14:00
Scientific Session 8: When to start and when to stop immunomodulatory treatment in MS 14:15-15:45
Scientific Session 9: Neuromyelitis optica spectrum disease (NMOSD) 14:15-15:45
Scientific Session 10: Hunting for new targets to fight neurodegeneration 14:15-15:45
Educational Session 20 (MAGNIMS): MRI and the diagnosis of multiple sclerosis 14:15-15:45
Educational Session 21 (RIMS): Symptomatic treatment of MS: how to manage fatigue and gait dysfunction? 14:15-15:45
Meet the Expert 3: Treatment 14:15-15:15
Free Communications 4: Treatment 16:15-17:15
Free Communications 5: Imaging 16:15-17:15
Free Communications 6: Immunology/Neurobiology 16:15-17:15
Hot Topic 10: Access to and restrictions in MS therapy across countries 16:15-17:00
Case-based Educational Session 22: MOG-Ab phenotype 16:15-17:15
Meet the Expert 4: Pregnancy 16:15-17:15
Poster Session 2 17:15-19:15
Satellite Symposium 8: Brain volume loss and biomarkers: how will new research change the clinical management of MS?                          18:15-19:15
Satellite Symposium 9: Combining DMT: a potential way forward for RMS*        18:15-19:15

Freitag, 12. Oktober 2018

Satellite Symposium 10: Treatment sequencing in MS: how do you choose the right DMD for your patient? 07:30-08:30
Scientific Session 11: Approaches for tackling treatment failure 08:30-10:00
Scientific Session 12: Recent development in imaging for treatment monitoring 08:30-10:00
Scientific Session 13: Robotic and telehealth supported rehabilitation and exercise training in MS 08:30-10:00
Educational Session 23: NMO-spectrum disorders: current concepts and clinical management 08:30-10:00
Educational Session 24: The use of stem cells in MS: where are we and where are we going? 08:30-10:00
Scientific Session 14: Recent developments in progressive MS 10:30-12:00
Scientific Session 15: „MS spectrum disease“? 10:30-12:00
Scientific Session 16: Understanding MS by integrating clinical and multiOMICs data 10:30-12:00
Educational Session 25: MS mimicks: genetic disorders 10:30-12:00
Educational Session 26 (MAGNIMS): From structural and functional connectivity to clinical impairment in multiple sclerosis 10:30-12:00
Google Hangout 12:00-13:00
Poster Session 3 12:15-14:15
Satellite Symposium 11: Switching MS treatments: patient trajectory, prior response and real world evidence to inform decision-making 13:00-14:00
Satellite Symposium 12: Data • Analysis • Technology • Application making it real 13:00-14:00
Scientific Session 17: Late Breaking News 14:15-15:30
Plenary Session 2 – ECTRIMS Awards, ECTRIMS Honorary Members, Confavreux Lecture and ECTRIMS 2018 Highlights 16:00-18:00

Kerstin Huber-Eibl, MS-Gesellschaft Wien